Xmrk in medaka: A new genetic melanoma model

Journal of Investigative Dermatology

Volumn 130, Issue 1, 2010, Pages 14-17

  Patton, E Elizabeth ^a   Nairn, Rodney S ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN BCL 2;

CANCER GENETICS; DISEASE COURSE; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; FISH; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HISTOPATHOLOGY; MELANOMA; NONHUMAN; NOTE; ONCOGENE; PRIORITY JOURNAL; XMRK GENE; ZEBRA FISH;

EID: 72049116824     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.293     Document Type: Note

References (20)

1. Amatruda JF, Patton EE (2008) Genetic models of cancer in zebrafish. Int Rev Cell Mol Biol 271:1-34
2. Breider H (1952) [Melanosarcomata, formation of melanin and homologous cell mechanisms; investigations on fishes.] Strahlentherapie 88:619-639
3. Bunton TE (1996) Experimental chemical carcinogenesis in fish. Toxicol Pathol 24:603-618
4. Butler A P, Trono D, Beard R et al. (2007) Melanoma susceptibility and cell cycle genes in Xiphophorus hybrids. Mol Carcinog 46:685-691
5. Chin L, Garraway LA, Fisher DE (2006) Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 20:2149-2182
6. Dankort D, Curley D P, Cartlidge RA et al. (2009) Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41:544-552
7. Dhomen N, Reis-Filho JS, da Rocha Dias S et al. (2009) Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 15:294-303
8. Goel VK, Ibrahim N, Jiang G et al. (2009) Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice. Oncogene 28:2289-2298
9. Gray-Schopfer V, Wellbrock C, Marais R (2007) Melanoma biology and new targeted therapy. Nature 445:851-857
10. Kelsh RN (2004) Genetics and evolution of pigment patterns in fish. Pigment Cell Res 17:326-336
11. Kelsh RN, Inoue C, Momoi A et al. (2004) The Tomita collection of medaka pigmentation mutants as a resource for understanding neural crest cell development. Mech Dev 121:841-859
12. Linos E, Swetter SM, Cockburn MG et al. (2009) Increasing burden of melanoma in the United States. J Invest Dermatol 129:1666-1674
13. McGill GG, Horstmann M, Widlund HR et al. (2002) Bcl2 regulation by the melanocyte master regulator MITF modulates lineage survival and melanoma cell viability. Cell 109:707-718
14. Meierjohann S, Schartl M (2006) From Mendelian to molecular genetics: the Xiphophorus melanoma model. Trends Genet 22:654-661
15. Patton EE, Zon LI (2001) The art and design of genetic screens: zebrafish. Nat Rev Genet 2:956-966
16. Patton EE, Widlund HR, Kutok JL et al. (2005) BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 15:249-254
17. Schartl M, Wilde B, Laisney JAGC et al. (2010) A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies. J Invest Dermatol 130:249-58
18. White RM, Zon LI. (2008) Melanocytes in development, regeneration, and cancer. Cell Stem Cell 3:242-252
19. Yu H, McDaid R, Lee J et al. (2009) The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes. Am J Pathol 174:2367-2377
20. Zon LI, Peterson RT (2005) In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4:35-44